Caris Life Sciences, Inc. (CAI) reporting calendar
Caris Life Sciences, Inc. files periodic reports with the SEC as CAI on Nasdaq. Atlas tracks 4 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 28 Jul 2026 – 23 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 8 May 2026
- Reports on record
- 4
How this window is derived. Derived from this issuer's own filing history: 4 periods at a median 92-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open CAI market profile
Latest filing on SEC EDGAR ↗
Services-Medical Laboratories reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 8 May 2026 | 38 days | 0002019410-26-000044 |
| 10-K | 31 Dec 2025 | 3 Mar 2026 | 62 days | 0002019410-26-000016 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0002019410-25-000028 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0002019410-25-000012 |
Source: SEC EDGAR company submissions for CIK 0002019410. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.